TCL Archive In Brief: William Peters To Leave Duke To Head Michigan Cancer Foundation, Prentis Center April 7, 1995
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC April 30, 2010
TCL Archive Carcinogenicity Test For Cis-Platinum Needed, DCT Says, But Declines To Pay For It June 16, 1978
TCL Archive In Brief: ASTRO Officers Named; AACR Fellowships Available; NRC Won’t Revoke NIH License November 10, 1995
